<DOC>
	<DOC>NCT00049985</DOC>
	<brief_summary>The purpose of this study is to determine whether increasing hemoglobin concentration in patients with heart failure and anemia will improve the patients' functional status, including exercise tolerance and New York Heart Association (NYHA) classification.</brief_summary>
	<brief_title>Heart Failure and Anemia</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<criteria>At least 21 years of age Symptomatic CHF for at least 3 months Limited exercise tolerance on a treadmill Reduced left ventricular ejection fraction Stable heart failure medication Hemoglobin concentration between 9.0 and 12.5 g/dL Hypertension Unstable angina pectoris or recent myocardial infarction Likely to receive cardiac transplant Unable to do cardiopulmonary exercise testing Major organ transplant (e.g., lung, liver, heart) or in renal replacement therapy (e.g., dialysis) Recent or current treatment for malignancy Systemic hematologic disease Anemia due to acute or chronic bleeding Recent epogen or darbepoetin alfa therapy Recent blood transfusion</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>